CATEGORIES

07.04.2016

07.04.2016 16:51

MaxiVAX announces promising results from its phase 1 anti-cancer clinical trial

MaxiVAX SA, a private Swiss biotech company, today announced promising results from a ground-breaking clinical phase 1 trial at the Geneva University Hospital (HUG) with its proprietary cancer vaccination product, MVX-ONCO-1, in 15 patients suffering from various solid cancers at an advanced stage. Phase 2 trial will start in the second half of 2016.

07.04.2016 12:30

EUREKA Innovation Award for a Swiss-led project

Opto-Brain, a 2.5 million Euro project led by a Swiss startup, NeMoDevices, has been announced victor of the EUREKA Innovation Award 2015/2016 in the category Innovators for Tomorrow. The project coordinator, Emanuela Keller, Founder of NeMoDevices will have the honour to receive the prize worth 16’000 Euro.

07.04.2016 08:36

Sky-Futures and Flyability Partner for Internal Tank Inspections with Drones

Sky-Futures and Flyability announce the first commercial application of drones for internal tank inspections without needing humans inside for the global oil and gas industry.

06.04.2016

06.04.2016 15:20

Un partenariat stratégique pour accélerer Pryv

Début avril la startup Pryv a annoncé avoir rejoint la Konica Minolta Leading Edge Partners Community. Pour la startup vaudoise spécialisée dans la gestion de données liées à la cybersanté, cette communauté constituée de plus de 110 partenaires au niveau mondial présente de nouvelles perspectives en matière de collaboration, développement et commercialisation de sa solution « E-Health Middleware » Pryv.io. Pour la startup ce rapprochement devrait accélérer son développement ces prochains mois.

05.04.2016

05.04.2016 16:21

AC Immune’s publication on the treatment of Down Syndrome

AC Immune, a Swiss-based biopharmaceutical company focused on neurodegenerative diseases, today announced the publication of a ground-breaking scientific publication on an anti-Abeta vaccine potentially signalling a way to treat cognitive deficits in people with Down syndrome (DS) which affects one in about 700 new-borns.

05.04.2016 14:14

eSMART, qipp und Losinger Marazzi schliessen eine Partnerschaft für das Projekt Greencity ab

Auf einer ehemaligen Industriebrache in Zürich Süd entsteht das zukunftsweisende Quartier Greencity, welches sich ganz den Prinzipien der Nachhaltigkeit verpflichtet. Das Quartier ist das erste vom Trägerverein Energiestadt zertifizierte „2’000-Watt-Areal“ der Schweiz. Beim Projekt von Losinger Marazzi spielen die Jungunternehmen eSmart und qipp eine wichtige Rolle.

04.04.2016

04.04.2016 15:20

Cofoundme on track

Since its establishment in 2014, cofoundme, a match-making platform for startups and talents, has registered a monthly user expansion of up to 20%. The company is embarking on expanding further abroad.

Show All

Events

06.04.2017 08:00 - 22:00

Seedstars Summit 2017: The Entrepreneurship Forum For Emerging Markets SwissTech Convention Center, Lausanne

MEET US

Show All

Trainings

28.03.2017 12:00 - 14:00

Valuation of emerging life sciences companies Biopôle IV. Route de la Corniche 3, Floor -1, Room 1

Top viewed

Show All

Video

Tweets

Principal

24.03.2017
Editorial

Evidence of great potential

Partners

Contributors